Skip to content
Recall Observatory FDA recall evidence

Drug product

Valsartan and Hydrochlorothiazide (HCTZ) Tablets, USP 80 mg/12.5 mg tablets, 90 count-count bottle, Rx Only, Manufactured by: Arrow Pharma (Malta) Ltd. India, Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054, NDC 0591-2315-19.

D-0981-2018

July 16, 2018

Class II

Product summary

Firm
Teva Pharmaceuticals USA
Event
Event 80538
Status
Ongoing
Classification
Class II
Quantity
56,603 bottles
Official record key
drug-enforcement:D-0981-2018

Official wording

Reason: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Code information: Lot # 1191191M, 1191192M, 1191193M, 1191194M, 1191195M, 1238466M, 1238467M, 1253261M 1256125M, 1277709M

Distribution pattern: Product was distributed throughout the United States, including Hawaii and Puerto Rico

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations